US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
ES2287206T3
(es)
|
1991-03-01 |
2007-12-16 |
Dyax Corporation |
Proceso para el desarrollo de mini-proteinas de union.
|
US20050084885A1
(en)
*
|
1994-01-18 |
2005-04-21 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
AU726759B2
(en)
*
|
1994-08-20 |
2000-11-23 |
Gendaq Limited |
Improvements in or relating to binding proteins for recognition of DNA
|
ATE407205T1
(de)
|
1994-08-20 |
2008-09-15 |
Gendaq Ltd |
Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
|
WO2000073434A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Sangamo Biosciences, Inc. |
Gene switches
|
US7285416B2
(en)
|
2000-01-24 |
2007-10-23 |
Gendaq Limited |
Regulated gene expression in plants
|
US7262055B2
(en)
|
1998-08-25 |
2007-08-28 |
Gendaq Limited |
Regulated gene expression in plants
|
GB9710807D0
(en)
*
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
WO1999021991A1
(en)
*
|
1997-10-29 |
1999-05-06 |
Shanghai Second Medical University |
Bmzf12: a zinc finger gene cloned from bone marrow
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
WO1999045132A1
(en)
|
1998-03-02 |
1999-09-10 |
Massachusetts Institute Of Technology |
Poly zinc finger proteins with improved linkers
|
EP1068338A2
(de)
*
|
1998-03-06 |
2001-01-17 |
Oxford Biomedica (UK) Limited |
Verbesserte 'prodrug'-aktivierung.
|
DE69932813D1
(de)
|
1998-03-17 |
2006-09-28 |
Gendaq Ltd |
Nukleinsäurebindungsproteine
|
EP1112355A1
(de)
*
|
1998-09-14 |
2001-07-04 |
Aston University |
Gen- und proteinbibliotheken, und damit in zusammenhang stehende verfahren
|
US7897843B2
(en)
|
1999-03-23 |
2011-03-01 |
Mendel Biotechnology, Inc. |
Transcriptional regulation of plant biomass and abiotic stress tolerance
|
US20050086718A1
(en)
|
1999-03-23 |
2005-04-21 |
Mendel Biotechnology, Inc. |
Plant transcriptional regulators of abiotic stress
|
US6806062B1
(en)
*
|
1998-10-05 |
2004-10-19 |
Novozymes A/S |
Fungal transcriptional activator useful in methods for producing polypeptides
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US6599692B1
(en)
*
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
US6534261B1
(en)
*
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US7030215B2
(en)
*
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
US20030104526A1
(en)
*
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
WO2001000815A1
(en)
*
|
1999-05-28 |
2001-01-04 |
Sangamo Biosciences, Inc. |
Molecular switches
|
GB9915126D0
(en)
|
1999-06-30 |
1999-09-01 |
Imp College Innovations Ltd |
Control of gene expression
|
AU5912100A
(en)
*
|
1999-07-02 |
2001-01-22 |
Scripps Research Institute, The |
Method for determination of peptide-binding agent interaction
|
WO2001025417A2
(en)
*
|
1999-10-01 |
2001-04-12 |
Sangamo Biosciences, Inc. |
Dna library and its use in methods of selecting and designing polypeptides
|
PT1230345E
(pt)
|
1999-11-17 |
2008-09-23 |
Mendel Biotechnology Inc |
Genes de tolerância a stress ambiental
|
EP1950306A1
(de)
|
1999-11-17 |
2008-07-30 |
Mendel Biotechnology, Inc. |
Umweltstress-Toleranzgene
|
AU776576B2
(en)
|
1999-12-06 |
2004-09-16 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
AU2001226935B2
(en)
|
2000-01-24 |
2006-06-22 |
Gendaq Limited |
Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
|
DE60143192D1
(de)
*
|
2000-02-08 |
2010-11-18 |
Sangamo Biosciences Inc |
Zellen zur entdeckung von medikamenten
|
US20020061512A1
(en)
*
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
US6610489B2
(en)
*
|
2000-04-28 |
2003-08-26 |
Sangamo Biosciences, Inc. |
Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
|
US7923542B2
(en)
|
2000-04-28 |
2011-04-12 |
Sangamo Biosciences, Inc. |
Libraries of regulatory sequences, methods of making and using same
|
US20020064802A1
(en)
*
|
2000-04-28 |
2002-05-30 |
Eva Raschke |
Methods for binding an exogenous molecule to cellular chromatin
|
WO2001083819A2
(en)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Methods for designing exogenous regulatory molecules
|
ATE374249T1
(de)
*
|
2000-04-28 |
2007-10-15 |
Sangamo Biosciences Inc |
Datenbanken von regulatorischen sequenzen, methoden zu ihrer herstellung und verwendung
|
US20040039175A1
(en)
*
|
2000-05-08 |
2004-02-26 |
Yen Choo |
Modulation of viral gene expression by engineered zinc finger proteins
|
US6492117B1
(en)
|
2000-07-12 |
2002-12-10 |
Gendaq Limited |
Zinc finger polypeptides capable of binding DNA quadruplexes
|
WO2002008286A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Syngenta Participations Ag |
Zinc finger domain recognition code and uses thereof
|
US20030082561A1
(en)
*
|
2000-07-21 |
2003-05-01 |
Takashi Sera |
Zinc finger domain recognition code and uses thereof
|
WO2002015675A1
(en)
|
2000-08-22 |
2002-02-28 |
Mendel Biotechnology, Inc. |
Genes for modifying plant traits iv
|
AU2001285252A1
(en)
*
|
2000-08-25 |
2002-03-13 |
Gendaq, Ltd. |
Analysis of binding interactions
|
CA2421447C
(en)
|
2000-09-08 |
2012-05-08 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
US6905816B2
(en)
*
|
2000-11-27 |
2005-06-14 |
Intelligent Medical Devices, Inc. |
Clinically intelligent diagnostic devices and methods
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
US7026462B2
(en)
|
2000-12-07 |
2006-04-11 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
WO2002057308A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Sangamo Biosciences, Inc. |
Zinc finger polypeptides and their use
|
US7273923B2
(en)
|
2001-01-22 |
2007-09-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
WO2002060477A1
(en)
*
|
2001-01-31 |
2002-08-08 |
Human Genome Sciences, Inc. |
Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
|
US7067617B2
(en)
|
2001-02-21 |
2006-06-27 |
The Scripps Research Institute |
Zinc finger binding domains for nucleotide sequence ANN
|
ATE513040T1
(de)
*
|
2001-08-17 |
2011-07-15 |
Toolgen Inc |
Zinkfingerdomänenbibliotheken
|
WO2003027247A2
(en)
|
2001-09-24 |
2003-04-03 |
Sangamo Biosciences, Inc. |
Modulation of stem cells using zinc finger proteins
|
AU2002365796A1
(en)
*
|
2001-12-07 |
2003-06-17 |
Toolgen, Inc. |
Phenotypic screen of chimeric proteins
|
US20040259258A1
(en)
*
|
2001-12-07 |
2004-12-23 |
Kim Jin-Soo |
Regulation of prokaryotic gene expression with zinc finger proteins
|
US6899892B2
(en)
*
|
2001-12-19 |
2005-05-31 |
Regents Of The University Of Minnesota |
Methods to reduce body fat
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
ATE347593T1
(de)
*
|
2002-01-23 |
2006-12-15 |
Univ Utah Res Found |
Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
|
WO2003080809A2
(en)
*
|
2002-03-21 |
2003-10-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
JP2006513694A
(ja)
*
|
2002-06-11 |
2006-04-27 |
ザ スクリップス リサーチ インスティテュート |
人工転写因子
|
EP1527183B1
(de)
|
2002-07-26 |
2008-08-20 |
BASF Plant Science GmbH |
Neue selektionsverfahren
|
EP1529112A2
(de)
|
2002-08-07 |
2005-05-11 |
BASF Plant Science GmbH |
Mit einer abiotischen stressreaktion assoziierte proteine codierende nukleinsäuresequenzen
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
EP1581610A4
(de)
*
|
2002-09-05 |
2009-05-27 |
California Inst Of Techn |
Verwendung chimerer nukleasen zur stimulierung des gen-targeting
|
EP3249046B1
(de)
|
2002-09-18 |
2020-07-08 |
Mendel Biotechnology, Inc. |
Polynukleotide und polypeptide in pflanzen
|
US20070178454A1
(en)
*
|
2002-10-21 |
2007-08-02 |
Joung J K |
Context sensitive paralell optimization of zinc finger dna binding domains
|
WO2004099367A2
(en)
*
|
2002-10-23 |
2004-11-18 |
The General Hospital Corporation |
Methods for producing zinc finger proteins that bind to extended dna target sequences
|
WO2004046387A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for analysis of regulatory sequences
|
US7696334B1
(en)
*
|
2002-12-05 |
2010-04-13 |
Rosetta Genomics, Ltd. |
Bioinformatically detectable human herpesvirus 5 regulatory gene
|
US20060251643A1
(en)
*
|
2002-12-09 |
2006-11-09 |
Toolgen, Inc. |
Regulatory zinc finger proteins
|
EP2078753A3
(de)
|
2002-12-26 |
2010-12-15 |
Syngenta Participations AG |
Mit der Zellproliferation zusammenhängende Polypeptide und Verwendungen dafür
|
US20070042433A1
(en)
*
|
2003-03-26 |
2007-02-22 |
Jianxin Bao |
Neuregulin protein regulation of synaptic proteins
|
EP2194135A3
(de)
|
2003-04-15 |
2010-10-06 |
BASF Plant Science GmbH |
Nukleinsäuresequenzen aus Hefe, die für Proteine in Zusammenhang mit abiotischer Stressreaktion kodieren, sowie transgene Pflanzenzellen und Pflanzen mit erhöhter Umweltstressverträglichkeit
|
US8409861B2
(en)
*
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
AU2004263865B2
(en)
|
2003-08-08 |
2007-05-17 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7219018B2
(en)
*
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
US7216038B2
(en)
|
2003-09-11 |
2007-05-08 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
US7219017B2
(en)
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
WO2005028630A2
(en)
|
2003-09-19 |
2005-03-31 |
Sangamo Biosciences, Inc. |
Engineered zinc finger proteins for regulation of gene expression
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7534775B2
(en)
*
|
2004-04-08 |
2009-05-19 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating cardiac contractility
|
AU2005232665B2
(en)
*
|
2004-04-08 |
2010-05-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treating neuropathic and neurodegenerative conditions
|
US20060063231A1
(en)
*
|
2004-09-16 |
2006-03-23 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
BRPI0515902A
(pt)
|
2004-09-24 |
2008-08-12 |
Basf Plant Science Gmbh |
célula de planta, planta, semente, molécula de ácido nucleico isolada, construto de ácido nucleico, vetor, célula hospedeira, proteìna relacionada à tensão isolada, métodos de produção de uma planta transgênica e de modificação de toleráncia à tensão de uma planta, e, usos de um ácido nucleico que codifica srp e de toleráncia e/ou resistência aumentada à tensão ambiental e/ou ácido nucleico
|
WO2006078431A2
(en)
|
2004-12-22 |
2006-07-27 |
The University Of Iowa Research Foundation |
Compositions and methods related to modified retroviral vectors for restricted, site specific integration
|
EP1841870B1
(de)
|
2005-01-14 |
2013-09-04 |
University Of Guelph |
Stickstoffreguliertes zuckerwahrnehmungsgen und -protein sowie modulation davon
|
JP4988606B2
(ja)
*
|
2005-02-28 |
2012-08-01 |
サンガモ バイオサイエンシズ インコーポレイテッド |
抗血管新生方法及び組成物
|
CN101273141B
(zh)
|
2005-07-26 |
2013-03-27 |
桑格摩生物科学股份有限公司 |
外源核酸序列的靶向整合和表达
|
CN101365794A
(zh)
|
2005-08-12 |
2009-02-11 |
巴斯福植物科学有限公司 |
编码与非生物性胁迫应答相关的蛋白质的核酸序列和具有增加的环境胁迫耐受性的植物细胞及植物
|
AU2006287553A1
(en)
|
2005-09-08 |
2007-03-15 |
Chromatin, Inc. |
Plants modified with mini-chromosomes
|
JP2009520463A
(ja)
|
2005-11-28 |
2009-05-28 |
ザ スクリプス リサーチ インスティテュート |
Tnnのための亜鉛フィンガー結合ドメイン
|
BRPI0708976A2
(pt)
|
2006-03-24 |
2011-07-05 |
Basf Plant Science Gmbh |
célula de planta, planta, semente, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, proteìna relacionada com estresse isolada, métodos para produzir uma planta transgênica e para modificar a toleráncia a estresse de uma planta, e, usos de um ácido nucleico codificando srp e de toleráncia e/ou resistência aumentadas a estresse ambiental e/ou um ácido nucleico codificando srp
|
AU2007254251A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Sangamo Therapeutics, Inc. |
Methods and compositions for inactivation of dihydrofolate reductase
|
WO2007139898A2
(en)
|
2006-05-25 |
2007-12-06 |
Sangamo Biosciences, Inc. |
Variant foki cleavage half-domains
|
JP5551432B2
(ja)
*
|
2006-05-25 |
2014-07-16 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
遺伝子不活性化のための方法と組成物
|
CA2660040A1
(en)
|
2006-08-10 |
2008-02-14 |
Basf Plant Science Gmbh |
Method of increasing resistance against soybean rust in transgenic plants
|
CA2660485C
(en)
|
2006-08-11 |
2016-04-12 |
Sangamo Biosciences, Inc. |
Zinc finger nuclease-mediated homologous recombination
|
WO2008025711A2
(de)
|
2006-08-30 |
2008-03-06 |
Basf Plant Science Gmbh |
Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
|
EP2078087A1
(de)
|
2006-10-12 |
2009-07-15 |
BASF Plant Science GmbH |
Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
|
WO2008043849A2
(en)
|
2006-10-13 |
2008-04-17 |
Basf Plant Science Gmbh |
Plants with increased yield
|
CA2667414C
(en)
|
2006-11-13 |
2015-12-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the human glucocorticoid receptor locus
|
WO2008067840A1
(en)
|
2006-12-08 |
2008-06-12 |
Swetree Technologies Ab |
Plants having improved growth characteristics and method for making the same
|
EP3070169B1
(de)
|
2006-12-14 |
2018-05-09 |
Dow AgroSciences LLC |
Optimierte nichtkanonische zinkfingerproteine
|
CN101849016A
(zh)
|
2007-02-19 |
2010-09-29 |
羸创德固赛有限责任公司 |
具有甲酰基-thf-合成酶和/或甘氨酸切割活性的棒状杆菌
|
CA2584934A1
(en)
|
2007-04-17 |
2008-10-17 |
University Of Guelph |
Nitrogen-regulated sugar sensing gene and protein and modulation thereof
|
ATE489465T1
(de)
|
2007-04-26 |
2010-12-15 |
Sangamo Biosciences Inc |
Gezielte integration in die ppp1r12c-position
|
MX2009012556A
(es)
|
2007-05-22 |
2010-02-18 |
Basf Plant Science Gmbh |
Plantas con mayor tolerancia y/o resistencia al estres ambiental y mayor produccion de biomasa.
|
UA100855C2
(en)
|
2007-05-23 |
2013-02-11 |
Сингента Партисипейшнс Аг |
Polynucleotide markers
|
CN101883850B
(zh)
|
2007-07-12 |
2014-11-12 |
桑格摩生物科学股份有限公司 |
用于失活α-1,6岩藻糖基转移酶(FUT8)基因表达的方法和组合物
|
BRPI0817005A2
(pt)
|
2007-09-18 |
2019-09-24 |
Basf Plant Science Gmbh |
método para produzir uma célula de planta transgênica, uma planta ou uma parte da mesma com rendimento aumentado, molécula de ácido nucleico, construção de ácido nucleico, vetor, célula hospedeira, processo para produzir um polipeptídeo, polipeptídeo, anticorpo, núcleo de célula de planta transgênica, célula de planta, tecido de planta, material de propagação, material colhido, planta ou parte da mesma, semente, processo para identificar um composto, método para produzir uma composição agrícola, composição, e, uso de uma molécula de ácido nucleico
|
AU2008300548B2
(en)
|
2007-09-21 |
2015-04-09 |
Basf Plant Science Gmbh |
Plants with increased yield
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
EP2188384B1
(de)
|
2007-09-27 |
2015-07-15 |
Sangamo BioSciences, Inc. |
Schnelle in-vivo-identifizierung von biologisch aktiven nukleasen
|
CN101878307B
(zh)
*
|
2007-09-27 |
2017-07-28 |
陶氏益农公司 |
以5‑烯醇式丙酮酰莽草酸‑3‑磷酸合酶基因为靶的改造锌指蛋白
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
CA2703045C
(en)
|
2007-10-25 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted integration
|
CA2708094A1
(en)
|
2007-12-19 |
2009-06-25 |
Basf Plant Science Gmbh |
Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
|
CA2710543A1
(en)
|
2007-12-28 |
2009-07-09 |
Swetree Technologies Ab |
Woody plants having improved growth charateristics and method for making the same using transcription factors
|
WO2009106596A2
(en)
*
|
2008-02-27 |
2009-09-03 |
Basf Plant Science Gmbh |
Plants with increased yield
|
AU2009238629C1
(en)
|
2008-04-14 |
2015-04-30 |
Sangamo Therapeutics, Inc. |
Linear donor constructs for targeted integration
|
EP3851520A1
(de)
|
2008-04-30 |
2021-07-21 |
SanBio, Inc. |
Nervenregenerierende zellen mit veränderter dna-methylierung
|
US20110071214A1
(en)
*
|
2008-05-14 |
2011-03-24 |
Gregory John Allen |
Methods and compositions for the treatment of cancer
|
US9394531B2
(en)
|
2008-05-28 |
2016-07-19 |
Sangamo Biosciences, Inc. |
Compositions for linking DNA-binding domains and cleavage domains
|
US8597912B2
(en)
|
2008-06-10 |
2013-12-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for generation of Bax-and Bak-deficient cell lines
|
US8048307B2
(en)
*
|
2008-08-14 |
2011-11-01 |
Brent Lee |
Dynamic filtration device using centrifugal force
|
BRPI0917855A2
(pt)
|
2008-08-19 |
2015-08-18 |
Basf Plant Science Gmbh |
Métodos para produzir uma célula de planta transgênica, planta ou parte da mesma, para produzir uma composição agrícola, para produzir uma planta transgênica, e para aumentar o rendimento, célula de planta transgênica, planta ou parte da mesma, semente, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, processos para produzir um polipeptídeo, e para identificar um composto, polipeptídeo, anticorpo, tecido de planta, material de propagação material colhido ou planta, composição, e, uso de uma proteína relacionada a rendimento ou proteína relacionada a estresse e a rendimento.
|
CA2734235C
(en)
|
2008-08-22 |
2019-03-26 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted single-stranded cleavage and targeted integration
|
US20110195843A1
(en)
|
2008-09-23 |
2011-08-11 |
Basf Plant Science Gmbh |
Plants with Increased Yield (LT)
|
MX2011004270A
(es)
|
2008-10-23 |
2011-07-13 |
Basf Plant Science Gmbh |
Plantas con rendimiento aumentado (nue).
|
CN104745624A
(zh)
|
2008-10-23 |
2015-07-01 |
巴斯夫植物科学有限公司 |
生产具有增加的γ-氨基丁酸(GABA)含量的转基因细胞的方法
|
JP5756016B2
(ja)
|
2008-10-29 |
2015-07-29 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物
|
EP2350291A4
(de)
|
2008-11-03 |
2012-02-22 |
Swetree Technologies Ab |
Pflanzliches material, pflanzen und verfahren zur herstellung einer pflanze mit veränderten lignin-eigenschaften
|
US20110318830A1
(en)
*
|
2008-11-12 |
2011-12-29 |
The Regents Of The University Of California |
Compositions and methods for re-programming and re-differentiating cells
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
US20110023157A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Equine genome editing with zinc finger nucleases
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
CA2745031C
(en)
|
2008-12-04 |
2018-08-14 |
Sangamo Biosciences, Inc. |
Genome editing in rats using zinc-finger nucleases
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
US20110023159A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Ovine genome editing with zinc finger nucleases
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
US20110016542A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Canine genome editing with zinc finger nucleases
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
US8329986B2
(en)
|
2008-12-17 |
2012-12-11 |
Dow Agrosciences, Llc |
Targeted integration into the Zp15 locus
|
EP2199399A1
(de)
|
2008-12-17 |
2010-06-23 |
BASF Plant Science GmbH |
Ketokarotinoidproduktion in Pflanzen
|
JP5827132B2
(ja)
|
2009-02-04 |
2015-12-02 |
サンガモ バイオサイエンシズ インコーポレイテッド |
ニューロパチーを治療するための方法および組成物
|
US11235062B2
(en)
*
|
2009-03-06 |
2022-02-01 |
Metaqor Llc |
Dynamic bio-nanoparticle elements
|
US11096901B2
(en)
|
2009-03-06 |
2021-08-24 |
Metaqor Llc |
Dynamic bio-nanoparticle platforms
|
JP5932632B2
(ja)
|
2009-03-20 |
2016-06-15 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
改変された亜鉛フィンガータンパク質を使用したcxcr4の修飾
|
US9834787B2
(en)
*
|
2009-04-09 |
2017-12-05 |
Sangamo Therapeutics, Inc. |
Targeted integration into stem cells
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
EP2449135B1
(de)
|
2009-06-30 |
2016-01-06 |
Sangamo BioSciences, Inc. |
Schnelles screening biologisch aktiver nukleasen und isolation nukleasemodifizierter zellen
|
WO2011005849A1
(en)
|
2009-07-08 |
2011-01-13 |
Cellular Dynamics International, Inc. |
Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene
|
WO2011009801A1
(en)
|
2009-07-23 |
2011-01-27 |
Basf Plant Science Company Gmbh |
Plants with increased yield
|
EP2727600B1
(de)
|
2009-07-28 |
2019-03-27 |
Sangamo Therapeutics, Inc. |
Zinkfingerfusionsproteine zur supprimierung eines huntington gens
|
WO2011017315A2
(en)
*
|
2009-08-03 |
2011-02-10 |
Recombinetics, Inc. |
Methods and compositions for targeted gene modification
|
WO2011017293A2
(en)
*
|
2009-08-03 |
2011-02-10 |
The General Hospital Corporation |
Engineering of zinc finger arrays by context-dependent assembly
|
US8586526B2
(en)
|
2010-05-17 |
2013-11-19 |
Sangamo Biosciences, Inc. |
DNA-binding proteins and uses thereof
|
AU2010282958B2
(en)
|
2009-08-11 |
2015-05-21 |
Sangamo Therapeutics, Inc. |
Organisms homozygous for targeted modification
|
WO2011049627A1
(en)
|
2009-10-22 |
2011-04-28 |
Dow Agrosciences Llc |
Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
US20120227134A1
(en)
|
2009-11-17 |
2012-09-06 |
Basf Plant Science Company Gmbh |
Plants with Increased Yield
|
CA2782014C
(en)
|
2009-11-27 |
2021-08-31 |
Basf Plant Science Company Gmbh |
Optimized endonucleases and uses thereof
|
AU2011207769B2
(en)
|
2010-01-22 |
2015-05-28 |
Corteva Agriscience Llc |
Targeted genomic alteration
|
EP4328304A2
(de)
|
2010-02-08 |
2024-02-28 |
Sangamo Therapeutics, Inc. |
Manipulierte spaltungshalbdomänen
|
EP2660318A1
(de)
|
2010-02-09 |
2013-11-06 |
Sangamo BioSciences, Inc. |
Gezielte Genommodifikation mit partiell einzelsträngigen Donatormolekülen
|
US9567573B2
(en)
|
2010-04-26 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Genome editing of a Rosa locus using nucleases
|
US8772453B2
(en)
|
2010-05-03 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Compositions for linking zinc finger modules
|
CA2805442C
(en)
|
2010-07-21 |
2020-05-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of an hla locus
|
BR112013001685B1
(pt)
|
2010-07-23 |
2021-10-13 |
Sigma-Aldrich Co. Llc |
Método para editar pelo menos uma sequência cromossômica endógena em uma célula pela inserção de uma sequência na sequência cromossômica
|
AU2011312562B2
(en)
|
2010-09-27 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Methods and compositions for inhibiting viral entry into cells
|
CA2814143C
(en)
|
2010-10-12 |
2020-09-08 |
The Children's Hospital Of Philadelphia |
Methods and compositions for treating hemophilia b
|
CA2821547A1
(en)
|
2010-12-29 |
2012-07-05 |
Sigma-Aldrich Co. Llc |
Cells having disrupted expression of proteins involved in adme and toxicology processes
|
US9267123B2
(en)
|
2011-01-05 |
2016-02-23 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene correction
|
EP2694554A1
(de)
|
2011-04-08 |
2014-02-12 |
Gilead Biologics, Inc. |
Verfahren und zusammensetzungen zur normalisierung einer tumorvaskulatur mittels loxl2-hemmung
|
BR112013033448B1
(pt)
|
2011-06-30 |
2022-01-25 |
Sigma-Aldrich Co. Llc |
Método para produzir uma proteína recombinante com um padrão de glicosilação semelhante ao de humano
|
EP3461896B1
(de)
|
2011-07-15 |
2023-11-29 |
The General Hospital Corporation |
Verfahren zur transkription einer aktivatorähnlichen effektoranordnung
|
CA2841541C
(en)
|
2011-07-25 |
2019-11-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
KR102209330B1
(ko)
|
2011-09-21 |
2021-01-29 |
상가모 테라퓨틱스, 인코포레이티드 |
이식 유전자 발현의 조절을 위한 방법 및 조성물
|
WO2013050318A1
(en)
|
2011-10-07 |
2013-04-11 |
Basf Plant Science Company Gmbh |
Method of producing plants having increased resistance to pathogens
|
SG11201400701WA
(en)
*
|
2011-10-11 |
2014-08-28 |
Aliophtha Ag |
Regulation of receptor expression through delivery of artificial transcription factors
|
US9222105B2
(en)
|
2011-10-27 |
2015-12-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the HPRT locus
|
WO2013074999A1
(en)
|
2011-11-16 |
2013-05-23 |
Sangamo Biosciences, Inc. |
Modified dna-binding proteins and uses thereof
|
ES2733248T3
(es)
|
2012-01-11 |
2019-11-28 |
Sigma Aldrich Co Llc |
Producción de proteínas recombinantes con glicoformas simples
|
EP2806881A1
(de)
|
2012-01-27 |
2014-12-03 |
SanBio, Inc. |
Verfahren und zusammensetzungen zur modulation der angiogenese und vaskulogenese
|
CN105658792B
(zh)
|
2012-02-28 |
2020-11-10 |
西格马-奥尔德里奇有限责任公司 |
靶向组蛋白乙酰化
|
CA2865011C
(en)
|
2012-02-29 |
2021-06-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
CN104428414B
(zh)
|
2012-05-02 |
2022-01-21 |
陶氏益农公司 |
苹果酸脱氢酶的靶向修饰
|
ES2753135T3
(es)
|
2012-05-07 |
2020-04-07 |
Allergan Inc |
Método de tratamiento de DMAE en pacientes resistentes a terapia anti-VEGF
|
KR102116153B1
(ko)
|
2012-05-07 |
2020-05-27 |
상가모 테라퓨틱스, 인코포레이티드 |
도입유전자의 뉴클레아제-매개 표적화된 통합을 위한 방법 및 조성물
|
US9890364B2
(en)
|
2012-05-29 |
2018-02-13 |
The General Hospital Corporation |
TAL-Tet1 fusion proteins and methods of use thereof
|
EP2872625B1
(de)
|
2012-07-11 |
2016-11-16 |
Sangamo BioSciences, Inc. |
Zusammensetzungen und verfahren zur behandlung von lysosomalen speicherkrankheiten
|
EP2872154B1
(de)
|
2012-07-11 |
2017-05-31 |
Sangamo BioSciences, Inc. |
Verfahren und zusammensetzungen zur freisetzung von biologischen wirkstoffen
|
US10648001B2
(en)
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
EP2890780B8
(de)
|
2012-08-29 |
2020-08-19 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur behandlung eines genetischen leidens
|
WO2014039513A2
(en)
|
2012-09-04 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
|
CA2884162C
(en)
|
2012-09-07 |
2020-12-29 |
Dow Agrosciences Llc |
Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
|
UA119135C2
(uk)
|
2012-09-07 |
2019-05-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб отримання трансгенної рослини
|
UA118090C2
(uk)
|
2012-09-07 |
2018-11-26 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб інтегрування послідовності нуклеїнової кислоти, що представляє інтерес, у ген fad2 у клітині сої та специфічний для локусу fad2 білок, що зв'язується, здатний індукувати спрямований розрив
|
US9597357B2
(en)
|
2012-10-10 |
2017-03-21 |
Sangamo Biosciences, Inc. |
T cell modifying compounds and uses thereof
|
US20150267176A1
(en)
|
2012-10-12 |
2015-09-24 |
The General Hospital Corporation |
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins
|
EP2929017A4
(de)
|
2012-12-05 |
2016-09-28 |
Sangamo Biosciences Inc |
Verfahren und zusammensetzungen zur regulierung von stoffwechselerkrankungen
|
EP2931901A1
(de)
|
2012-12-13 |
2015-10-21 |
Dow AgroSciences LLC |
Präzisions-gentargeting eines bestimmten ortes in mais
|
AU2014207618A1
(en)
|
2013-01-16 |
2015-08-06 |
Emory University |
Cas9-nucleic acid complexes and uses related thereto
|
JP6445462B2
(ja)
|
2013-02-07 |
2018-12-26 |
ザ ジェネラル ホスピタル コーポレイション |
Tale転写活性化因子
|
ES2768291T3
(es)
|
2013-02-14 |
2020-06-22 |
Univ Osaka |
Método para aislar una región genómica específica utilizando una molécula que se une específicamente a una secuencia de ADN endógena
|
WO2014130955A1
(en)
|
2013-02-25 |
2014-08-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
CA3161835A1
(en)
|
2013-03-15 |
2014-09-25 |
The General Hospital Corporation |
Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
WO2014153470A2
(en)
|
2013-03-21 |
2014-09-25 |
Sangamo Biosciences, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
RU2723130C2
(ru)
|
2013-04-05 |
2020-06-08 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Способы и композиции для встраивания экзогенной последовательности в геном растений
|
JP2016518142A
(ja)
|
2013-05-10 |
2016-06-23 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
ヌクレアーゼ媒介ゲノム遺伝子操作のための送達方法および組成物
|
US9873894B2
(en)
|
2013-05-15 |
2018-01-23 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treatment of a genetic condition
|
US10011850B2
(en)
|
2013-06-21 |
2018-07-03 |
The General Hospital Corporation |
Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
|
EP3988654A1
(de)
|
2013-08-28 |
2022-04-27 |
Sangamo Therapeutics, Inc. |
Zusammensetzungen zur vernetzung von dna-bindungsdomänen und -spaltungsdomänen
|
CN110713995B
(zh)
|
2013-10-17 |
2023-08-01 |
桑格摩生物科学股份有限公司 |
用于核酸酶介导的基因组工程改造的递送方法和组合物
|
EP3057432B1
(de)
|
2013-10-17 |
2018-11-21 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen für nukleasevermitteltes genom-engineering in hämotopoietischen stammzellen
|
UA121459C2
(uk)
|
2013-11-04 |
2020-06-10 |
Дау Агросаєнсиз Елелсі |
Рекомбінантна молекула нуклеїнової кислоти для трансформації рослини сої
|
JP6633532B2
(ja)
|
2013-11-04 |
2020-01-22 |
ダウ アグロサイエンシィズ エルエルシー |
最適なトウモロコシ遺伝子座
|
BR102014027436B1
(pt)
|
2013-11-04 |
2022-06-28 |
Dow Agrosciences Llc |
Molécula de ácido nucleico recombinante, e método para a produção de uma célula vegetal transgênica
|
EP3066110B1
(de)
|
2013-11-04 |
2021-12-29 |
Corteva Agriscience LLC |
Optimale maispflanzen
|
CN111218447A
(zh)
|
2013-11-07 |
2020-06-02 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
EP3068905A4
(de)
|
2013-11-11 |
2017-07-05 |
Sangamo BioSciences, Inc. |
Verfahren und zusammensetzungen zur behandlung der huntington-krankheit
|
PT3492593T
(pt)
|
2013-11-13 |
2021-10-18 |
Childrens Medical Center |
Regulação da expressão de genes mediada por nucleases
|
CN105940013B
(zh)
|
2013-12-09 |
2020-03-27 |
桑格摩生物科学股份有限公司 |
用于治疗血友病的方法和组合物
|
SI3102673T1
(sl)
|
2014-02-03 |
2020-11-30 |
Sangamo Therapeutics, Inc. |
Postopki in sestavki za zdravljenje beta talasemije
|
EP3105254B1
(de)
|
2014-02-14 |
2019-11-20 |
Symvivo Corporation |
Hybride proteine und verwendungen davon
|
WO2015127439A1
(en)
|
2014-02-24 |
2015-08-27 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease-mediated targeted integration
|
KR102354633B1
(ko)
|
2014-03-04 |
2022-01-24 |
시그마-알드리치 컴퍼니., 엘엘씨 |
바이러스 내성 세포 및 이의 용도
|
EP3929279A1
(de)
|
2014-03-18 |
2021-12-29 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur regulierung der zinkfingerproteinexpression
|
WO2015164383A1
(en)
|
2014-04-22 |
2015-10-29 |
Q-State Biosciences, Inc. |
Models for parkinson's disease studies
|
US9522936B2
(en)
|
2014-04-24 |
2016-12-20 |
Sangamo Biosciences, Inc. |
Engineered transcription activator like effector (TALE) proteins
|
CN106413760B
(zh)
|
2014-05-08 |
2020-01-14 |
桑格摩生物科学股份有限公司 |
用于治疗亨廷顿病的方法和组合物
|
WO2015175642A2
(en)
|
2014-05-13 |
2015-11-19 |
Sangamo Biosciences, Inc. |
Methods and compositions for prevention or treatment of a disease
|
US20160060655A1
(en)
|
2014-05-30 |
2016-03-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods to treat latent viral infections
|
EP3152319A4
(de)
|
2014-06-05 |
2017-12-27 |
Sangamo BioSciences, Inc. |
Verfahren und zusammensetzungen zur nukleasekonstruktion
|
AR100874A1
(es)
|
2014-06-16 |
2016-11-09 |
Consejo Nac De Investig Científicas Y Técnicas (Conicet) |
Genes quiméricos y proteínas de resistencia oxidativa, y plantas transgénicas que incluyen los mismos
|
JP6784601B2
(ja)
|
2014-06-23 |
2020-11-11 |
ザ ジェネラル ホスピタル コーポレイション |
シークエンシングによって評価されるゲノムワイドでバイアスのないDSBの同定(GUIDE−Seq)
|
CA2954201A1
(en)
|
2014-07-08 |
2016-01-14 |
Vib Vzw |
Means and methods to increase plant yield
|
MX2017000555A
(es)
|
2014-07-14 |
2017-08-10 |
Univ Washington State |
Desactivacion de nanos que produce ablacion de celulas de linea germinal.
|
WO2016011381A1
(en)
|
2014-07-18 |
2016-01-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing cxcr4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
US9816074B2
(en)
|
2014-07-25 |
2017-11-14 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
WO2016014837A1
(en)
|
2014-07-25 |
2016-01-28 |
Sangamo Biosciences, Inc. |
Gene editing for hiv gene therapy
|
WO2016019144A2
(en)
|
2014-07-30 |
2016-02-04 |
Sangamo Biosciences, Inc. |
Gene correction of scid-related genes in hematopoietic stem and progenitor cells
|
CN113699113A
(zh)
|
2014-09-16 |
2021-11-26 |
桑格摩治疗股份有限公司 |
用于造血干细胞中核酸酶介导的基因组工程化和校正的方法和组合物
|
WO2016054326A1
(en)
|
2014-10-01 |
2016-04-07 |
The General Hospital Corporation |
Methods for increasing efficiency of nuclease-induced homology-directed repair
|
US10889834B2
(en)
|
2014-12-15 |
2021-01-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing targeted transgene integration
|
EP3247366A4
(de)
|
2015-01-21 |
2018-10-31 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zur identifizierung hochspezifischer nukleasen
|
US11248234B2
(en)
|
2015-02-11 |
2022-02-15 |
Basf Se |
Herbicide-resistant hydroxyphenylpyruvate dioxygenases
|
US10048275B2
(en)
|
2015-03-13 |
2018-08-14 |
Q-State Biosciences, Inc. |
Cardiotoxicity screening methods
|
EP4335918A3
(de)
|
2015-04-03 |
2024-04-17 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzung und verfahren zur genomeditierung von b-zellen
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
MX2017014446A
(es)
|
2015-05-12 |
2018-06-13 |
Sangamo Therapeutics Inc |
Regulacion de expresion genica mediada por nucleasa.
|
CA2986583A1
(en)
|
2015-05-21 |
2016-11-24 |
Q-State Biosciences, Inc. |
Optogenetics microscope
|
US10117911B2
(en)
|
2015-05-29 |
2018-11-06 |
Agenovir Corporation |
Compositions and methods to treat herpes simplex virus infections
|
JP2018516984A
(ja)
|
2015-05-29 |
2018-06-28 |
アジェノビア コーポレーション |
細胞を標的にしたhpv処置のための組成物および方法
|
US20180296537A1
(en)
|
2015-06-05 |
2018-10-18 |
Novartis Ag |
Methods and compositions for diagnosing, treating, and monitoring treatment of shank3 deficiency associated disorders
|
US9957501B2
(en)
|
2015-06-18 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
CA2991301A1
(en)
|
2015-07-13 |
2017-01-19 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
FI3331355T3
(fi)
|
2015-08-06 |
2024-06-17 |
Univ Missouri |
Sikojen lisääntymishäiriö- ja keuhkotulehdusoireyhtymävirukselle (PRRSV) resistentti sika ja soluja, joilla on muokattuja CD163-geenejä
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
JP2018530536A
(ja)
|
2015-09-11 |
2018-10-18 |
ザ ジェネラル ホスピタル コーポレイション |
ヌクレアーゼDSBの完全照合およびシーケンシング(FIND−seq)
|
IL258030B
(en)
|
2015-09-23 |
2022-08-01 |
Sangamo Therapeutics Inc |
Htt suppressing factors and their uses
|
KR20180053748A
(ko)
|
2015-09-30 |
2018-05-23 |
더 제너럴 하스피탈 코포레이션 |
시퀀싱(circle-seq)에 의한 절단 반응의 포괄적인 시험관내 보고
|
EP3380622A4
(de)
|
2015-11-23 |
2019-08-07 |
Sangamo Therapeutics, Inc. |
Verfahren und zusammensetzungen zum immunitäts-engineering
|
BR112018012235A2
(pt)
|
2015-12-18 |
2018-12-04 |
Sangamo Therapeutics Inc |
rompimento alvejado do receptor de células de mhc
|
CA3008413A1
(en)
|
2015-12-18 |
2017-06-22 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the t cell receptor
|
US20170202931A1
(en)
|
2016-01-15 |
2017-07-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of neurologic disease
|
JP7012650B2
(ja)
|
2016-02-02 |
2022-01-28 |
サンガモ セラピューティクス, インコーポレイテッド |
Dna結合ドメインと切断ドメインとを連結するための組成物
|
EP3433362B1
(de)
|
2016-03-23 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur erhöhung der effizienz der geneditierung
|
AU2017295720B2
(en)
|
2016-07-13 |
2021-07-22 |
Vertex Pharmaceuticals Incorporated |
Methods, compositions and kits for increasing genome editing efficiency
|
CN109844103A
(zh)
|
2016-07-21 |
2019-06-04 |
美克斯细胞有限公司 |
用于修饰基因组dna的方法和组合物
|
US11344511B2
(en)
|
2016-07-27 |
2022-05-31 |
Case Western Reserve University |
Compounds and methods of promoting myelination
|
US11193136B2
(en)
|
2016-08-09 |
2021-12-07 |
Vib Vzw |
Cellulose synthase inhibitors and mutant plants
|
PE20190568A1
(es)
|
2016-08-24 |
2019-04-22 |
Sangamo Therapeutics Inc |
Regulacion de la expresion genica usando nucleasas modificadas
|
SG10201913948PA
(en)
|
2016-08-24 |
2020-03-30 |
Sangamo Therapeutics Inc |
Engineered target specific nucleases
|
US10960085B2
(en)
|
2016-09-07 |
2021-03-30 |
Sangamo Therapeutics, Inc. |
Modulation of liver genes
|
KR20190062505A
(ko)
|
2016-10-03 |
2019-06-05 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Hpv-특이적 결합 분자
|
DK3757120T3
(da)
|
2016-10-04 |
2022-07-25 |
Prec Biosciences Inc |
Co-stimulerende domæner til anvendelse i genetisk modificerede celler
|
US20200172899A1
(en)
|
2016-10-14 |
2020-06-04 |
The General Hospital Corporation |
Epigenetically Regulated Site-Specific Nucleases
|
WO2018075736A1
(en)
|
2016-10-20 |
2018-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of fabry disease
|
CA3041668A1
(en)
|
2016-10-31 |
2018-05-03 |
Sangamo Therapeutics, Inc. |
Gene correction of scid-related genes in hematopoietic stem and progenitor cells
|
WO2018102665A1
(en)
|
2016-12-01 |
2018-06-07 |
Sangamo Therapeutics, Inc. |
Tau modulators and methods and compositions for delivery thereof
|
JP7416406B2
(ja)
|
2016-12-08 |
2024-01-17 |
ケース ウェスタン リザーブ ユニバーシティ |
機能的ミエリン産生を増進させるための方法および組成物
|
US20190390241A1
(en)
|
2017-01-24 |
2019-12-26 |
Sigma-Aldrich Co. Llc |
Viral resistant cells and culture systems
|
AU2018255975A1
(en)
|
2017-04-20 |
2019-08-15 |
Oregon Health & Science University |
Human gene correction
|
CA3061612A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
RU2019139045A
(ru)
|
2017-05-03 |
2021-06-03 |
Сангамо Терапьютикс, Инк. |
Способы и композиции для модификации гена регулятора трансмембранной проводимости при кистозном фиброзе (cftr)
|
EP4029943A1
(de)
|
2017-05-08 |
2022-07-20 |
Precision Biosciences, Inc. |
Nukleinsäuremoleküle, die einen manipulierten antigenrezeptor und ein hemmendes nukleinsäuremolekül codieren, und verfahren zur verwendung davon
|
EP3630849A4
(de)
|
2017-05-25 |
2021-01-13 |
The General Hospital Corporation |
Architekturen von zweiteiligem basiseditor (bbe) und typ-ii-c-cas9-zinkfinger-editing
|
US11512287B2
(en)
|
2017-06-16 |
2022-11-29 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell and/or HLA receptors
|
CA3068465A1
(en)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
|
EP4269560A3
(de)
|
2017-10-03 |
2024-01-17 |
Precision Biosciences, Inc. |
Modifizierte epidermale wachstumsfaktorrezeptorpeptide zur verwendung in genetisch modifizierten zellen
|
MX2020003536A
(es)
|
2017-10-03 |
2020-09-14 |
Juno Therapeutics Inc |
Moleculas de union especifica a virus de papiloma humano (hpv).
|
US20200299658A1
(en)
|
2017-11-01 |
2020-09-24 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
CA3079748A1
(en)
|
2017-11-09 |
2019-05-16 |
Sangamo Therapeutics, Inc. |
Genetic modification of cytokine inducible sh2-containing protein (cish) gene
|
AU2019209290B2
(en)
|
2018-01-17 |
2024-03-07 |
Vertex Pharmaceuticals Incorporated |
DNA-PK inhibitors
|
BR112020014315A2
(pt)
|
2018-01-17 |
2020-12-08 |
Vertex Pharmaceuticals Incorporated |
Inibidores de dna-pk
|
US20200361877A1
(en)
|
2018-01-17 |
2020-11-19 |
Vertex Pharmaceuticals Incorporated |
Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
|
EP3749350A4
(de)
|
2018-02-08 |
2021-12-01 |
Sangamo Therapeutics, Inc. |
Genetisch manipulierte zielspezifische nukleasen
|
CA3095084A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
T cells expressing a recombinant receptor, related polynucleotides and methods
|
CN112585276A
(zh)
|
2018-04-05 |
2021-03-30 |
朱诺治疗学股份有限公司 |
产生表达重组受体的细胞的方法和相关组合物
|
CA3095027A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
T cell receptors and engineered cells expressing same
|
CN112313246A
(zh)
|
2018-04-18 |
2021-02-02 |
桑格摩生物治疗股份有限公司 |
用于调节亨廷顿蛋白(htt)的锌指蛋白组合物
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
CN108802357B
(zh)
*
|
2018-06-27 |
2021-03-30 |
中南民族大学 |
一种用于免疫印迹分析的生物发光探针及其应用
|
JP2021536229A
(ja)
|
2018-08-23 |
2021-12-27 |
サンガモ セラピューティクス, インコーポレイテッド |
操作された標的特異的な塩基エディター
|
JP2022500052A
(ja)
|
2018-09-18 |
2022-01-04 |
サンガモ セラピューティクス, インコーポレイテッド |
プログラム細胞死1(pd1)特異的ヌクレアーゼ
|
US20220090047A1
(en)
|
2018-12-21 |
2022-03-24 |
Precision Biosciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
WO2020146805A1
(en)
|
2019-01-11 |
2020-07-16 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
SG11202107720UA
(en)
|
2019-01-31 |
2021-08-30 |
Agency Science Tech & Res |
Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
|
WO2020163396A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Adenine dna base editor variants with reduced off-target rna editing
|
AU2019428629A1
(en)
|
2019-02-06 |
2021-01-28 |
Sangamo Therapeutics, Inc. |
Method for the treatment of mucopolysaccharidosis type I
|
MX2021012152A
(es)
|
2019-04-02 |
2021-11-03 |
Sangamo Therapeutics Inc |
Metodos para el tratamiento de beta-talasemia.
|
JP7286796B2
(ja)
|
2019-04-03 |
2023-06-05 |
プレシジョン バイオサイエンシズ,インク. |
マイクロrna適合shrna(shrnamir)を含む遺伝子改変免疫細胞
|
CA3136265A1
(en)
|
2019-04-05 |
2020-10-08 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
CN113766921A
(zh)
|
2019-04-23 |
2021-12-07 |
桑格摩生物治疗股份有限公司 |
染色体9开放阅读框72基因表达的调节物及其用途
|
BR112021021200A2
(pt)
|
2019-05-01 |
2021-12-21 |
Juno Therapeutics Inc |
Células expressando um receptor quimérico de um locus cd247 modificado, polinucleotídeos relacionados e métodos
|
MX2021013219A
(es)
|
2019-05-01 |
2022-02-17 |
Juno Therapeutics Inc |
Celulas que expresan un receptor recombinante de un locus de tgfbr2 modificado, polinucleotidos relacionados y metodos.
|
WO2020252381A2
(en)
|
2019-06-13 |
2020-12-17 |
Allogene Therapeutics, Inc. |
Anti-talen antibodies and uses thereof
|
US20220273715A1
(en)
|
2019-07-25 |
2022-09-01 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
WO2021035054A1
(en)
|
2019-08-20 |
2021-02-25 |
Precision Biosciences, Inc. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
EP4041754A1
(de)
|
2019-10-02 |
2022-08-17 |
Sangamo Therapeutics, Inc. |
Zinkfingerprotein-transkriptionsfaktoren zur hemmung der alpha-synnuclein expression
|
JP2022550608A
(ja)
|
2019-10-02 |
2022-12-02 |
サンガモ セラピューティクス, インコーポレイテッド |
プリオン病の治療のためのジンクフィンガータンパク質転写因子
|
DK3812472T3
(da)
|
2019-10-21 |
2023-02-20 |
Univ Freiburg Albert Ludwigs |
Virkelig uvildig in vitro-undersøgelse til profilering af off-target-aktivitet af en eller flere målspecifikke programmerbare nukleaser i celler (abnoba-seq)
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
US20210130828A1
(en)
|
2019-11-01 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Gin recombinase variants
|
AU2020376048A1
(en)
|
2019-11-01 |
2022-06-02 |
Sangamo Therapeutics, Inc. |
Compositions and methods for genome engineering
|
EP4069285A1
(de)
|
2019-12-06 |
2022-10-12 |
Precision BioSciences, Inc. |
Methoden zur krebsimmuntherapie unter verwendung von lymphodepletionsregimen und allogenen cd19-, cd20- oder bcma-car-t-zellen
|
KR20220131273A
(ko)
|
2020-01-22 |
2022-09-27 |
상가모 테라퓨틱스, 인코포레이티드 |
타우 발현을 억제시키기 위한 아연 핑거 단백질 전사 인자
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
US20230263121A1
(en)
|
2020-03-31 |
2023-08-24 |
Elo Life Systems |
Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
|
CN115803435A
(zh)
|
2020-05-06 |
2023-03-14 |
塞勒克提斯公司 |
用于在细胞基因组中靶向插入外源序列的方法
|
EP4146284A1
(de)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Verfahren zur genetischen modifizierung von zellen zur freisetzung therapeutischer proteine
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
CN115835873A
(zh)
|
2020-05-13 |
2023-03-21 |
朱诺治疗学股份有限公司 |
用于产生表达重组受体的供体分批细胞的方法
|
CN116234558A
(zh)
|
2020-06-26 |
2023-06-06 |
朱诺治疗学有限公司 |
条件性地表达重组受体的工程化t细胞、相关多核苷酸和方法
|
CA3189338A1
(en)
|
2020-07-16 |
2022-01-20 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
EP4192875A1
(de)
|
2020-08-10 |
2023-06-14 |
Precision BioSciences, Inc. |
Antikörper und fragmente spezifisch für b-zellreifungsantigen und verwendungen davon
|
EP4204545A2
(de)
|
2020-08-25 |
2023-07-05 |
Kite Pharma, Inc. |
T-zellen mit verbesserter funktionalität
|
CA3196599A1
(en)
|
2020-09-25 |
2022-03-31 |
Sangamo Therapeutics, Inc. |
Zinc finger fusion proteins for nucleobase editing
|
TW202229320A
(zh)
|
2020-10-02 |
2022-08-01 |
美商聖加莫治療股份有限公司 |
用於抑制α-突觸核蛋白(SYNUCLEIN)表現之新穎鋅指蛋白轉錄因子
|
US20230365995A1
(en)
|
2020-10-07 |
2023-11-16 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
EP4232461A1
(de)
|
2020-10-23 |
2023-08-30 |
ELO Life Systems, Inc. |
Verfahren zur herstellung von vanillepflanzen mit verbessertem geschmack und agronomischer herstellung
|
KR20230090367A
(ko)
|
2020-11-04 |
2023-06-21 |
주노 쎄러퓨티크스 인코퍼레이티드 |
변형된 불변 cd3 이뮤노글로불린 슈퍼패밀리 쇄 유전자좌로부터 키메라 수용체를 발현하는 세포 및 관련 폴리뉴클레오티드 및 방법
|
CN117042600A
(zh)
|
2020-11-16 |
2023-11-10 |
猪改良英国有限公司 |
具有经编辑的anp32基因的抗甲型流感动物
|
WO2022165111A1
(en)
|
2021-01-28 |
2022-08-04 |
Precision Biosciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
CA3235185A1
(en)
|
2021-10-19 |
2023-04-27 |
Cassandra GORSUCH |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
TW202328201A
(zh)
|
2021-11-09 |
2023-07-16 |
美商安進公司 |
產生抗體肽軛合物的方法
|
WO2023091910A1
(en)
|
2021-11-16 |
2023-05-25 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
WO2023105244A1
(en)
|
2021-12-10 |
2023-06-15 |
Pig Improvement Company Uk Limited |
Editing tmprss2/4 for disease resistance in livestock
|
AU2022421236A1
(en)
|
2021-12-22 |
2024-06-27 |
Sangamo Therapeutics, Inc. |
Novel zinc finger fusion proteins for nucleobase editing
|
WO2023131616A1
(en)
|
2022-01-05 |
2023-07-13 |
Vib Vzw |
Means and methods to increase abiotic stress tolerance in plants
|
WO2023131637A1
(en)
|
2022-01-06 |
2023-07-13 |
Vib Vzw |
Improved silage grasses
|
WO2023144199A1
(en)
|
2022-01-26 |
2023-08-03 |
Vib Vzw |
Plants having reduced levels of bitter taste metabolites
|
WO2023168397A1
(en)
|
2022-03-04 |
2023-09-07 |
Sigma-Aldrich Co. Llc |
Metabolic selection via the asparagine biosynthesis pathway
|
WO2024013514A2
(en)
|
2022-07-15 |
2024-01-18 |
Pig Improvement Company Uk Limited |
Gene edited livestock animals having coronavirus resistance
|
WO2024073686A1
(en)
|
2022-09-30 |
2024-04-04 |
Sigma-Aldrich Co. Llc |
Metabolic selection via the serine biosynthesis pathway
|
WO2024073692A1
(en)
|
2022-09-30 |
2024-04-04 |
Sigma-Aldrich Co. Llc |
Metabolic selection via the glycine-formate biosynthesis pathway
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|